Inflammation-driven carcinogenesis in ulcerative colitis: Molecular and immunological pathways
World Journal of Gastrointestinal Oncology · 15.11.2026 · 18 (11)
DOI: 10.4251/wjgo.125273 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastrointestinal Oncology, online erschienen am 15.11.2026. Verfasst von Paulina Delgado-Gonzalez und 4 weiteren Autor:innen. Die Arbeit nennt 191 Literaturangaben.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a chronic inflammatory bowel disorder resulting from a genetic predisposition, environmental factors, and immune system dysfunction. Chronic mucosal inflammation is an established precursor of colitis-associated colorectal cancer; however, the molecular transition from persistent inflammation to neoplasia remains unclear. The pathogenesis of UC involves disruption of the intestinal barrier, resulting in dysregulated innate immune responses mediated by toll-like receptor signaling and NOD-like receptor family pyrin domain containing 3 inflammasome activation, followed by polarized adaptive responses mediated by T helper 2 and T helper 17 cells. Intestinal dysbiosis further influences immunity by facilitating DNA damage through oxidative stress and metabolic alterations. Mechanisms of immune evasion, including regulatory T-cell dysfunction and the activation of anti-apoptotic pathways such as Janus kinase/signal transducer and activator of transcription and nuclear factor kappa-light-chain-enhancer of activated B cells, perpetuate chronic inflammation. This pro-inflammatory environment, characterized by interleukin-6 and tumor necrosis factor alpha signaling, promotes genomic instability and establishes oncogenic conditions favorable for gastrointestinal malignancies. The transition from UC to cancer is sustained by microbe-induced inflammation and immune evasion. This review aims to synthesize current knowledge of the immunological and inflammatory mechanisms in UC, highlighting the functions of innate and adaptive immunity, dysbiosis, oxidative stress, and immune evasion, while also addressing how these findings contribute to biomarker identification and personalized therapeutic approaches in gastrointestinal oncology.
Zitieren
APA
Delgado-Gonzalez, P., Quiroz-Reyes, A. G., Simental-Mendía, M. A., Loaiza-Gutiérrez, V. L., & Garza-Treviño, E. N. (2026). Inflammation-driven carcinogenesis in ulcerative colitis: Molecular and immunological pathways. World Journal of Gastrointestinal Oncology, 18(11). https://doi.org/10.4251/wjgo.125273
Vancouver
Delgado-Gonzalez P, Quiroz-Reyes AG, Simental-Mendía MA, Loaiza-Gutiérrez VL, Garza-Treviño EN. Inflammation-driven carcinogenesis in ulcerative colitis: Molecular and immunological pathways. World Journal of Gastrointestinal Oncology. 2026;18(11). doi:10.4251/wjgo.125273
BibTeX
@article{DelgadoGonzalez2026,
author = {Delgado-Gonzalez, Paulina and Quiroz-Reyes, Adriana G and Simental-Mendía, Mario A and Loaiza-Gutiérrez, Verónica L and Garza-Treviño, Elsa N},
title = {Inflammation-driven carcinogenesis in ulcerative colitis: Molecular and immunological pathways},
journal = {World Journal of Gastrointestinal Oncology},
year = {2026},
volume = {18},
number = {11},
doi = {10.4251/wjgo.125273}
}
EUVIMED